Menu ×


Gene Panel Market Segmentation by Technology (Amplicon-Based and Hybridization-Based); by Design (Predesigned and Customized); by Application (Cancer Risk Assessment, Pharmacogenetics, Congenital Disorders, and Others); and by End User (Research Institutes, Hospital, Diagnosis Centers, Pharmaceutical Companies, and Others) – Global Demand Analysis & Opportunity Outlook 2030

  • Text Size:

Extensive insights into the Growth of Gene Panel Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More


·   September 02, 2021: Agilent Technologies Inc. announced the agreement with Visiopharm, for worldwide distribution of CE-IVD, which is an artificial intelligence (AI)-driven precision pathology technology. This technology can be used for early diagnosis of cancer and other diseases.

·   December 03, 2018: JenaValve Technology, Inc., announced the FDA approval of its new technology IDE, for the treatment of patients with congenital disorders.

Global Gene Panel Market Highlights over 2022 – 2030

The global gene panel market is estimated to grow at a CAGR of ~22% over the forecast period, i.e., 2022 – 2030. The growth of the market can be attributed to the growth in next generation sequencing technology, escalating genetic testing, and scientific advancement. Gene panels are used to analyze multiple genes to diagnose chances of congenital diseases, and cancer, among other diseases. The increasing prevalence of genetic disorders, such as, Down syndrome, Huntington’s disease, sickle cell disease, Tay-sachs disease, and others, is estimated to boost the market growth. Furthermore, with the surge in health awareness amongst individuals, the demand for early diagnosis is also rising. As a result, lots of couples opt for genetic testing before planning a child, or during pregnancy. The growing application of gene panel to facilitate low cost, fast and accurate testing, is estimated to boost the market growth. 

Gene Panel Market

Moreover, increasing prevalence of cancer, caused by rising presence of carcinogens in the environment is foreseen to propel the market growth. According to the statistics by the World Health Organization (WHO), cancer caused around 9.6 million deaths in 2018, which touched 10 million in 2020. Out of the 10 million, most deaths were attributed to lung cancer, which was 1.8 million deaths, followed by colon and rectum cancer, 0.935 million deaths. In terms of prevalence, 2.26 new cases of breast cancer were reported in 2020 itself. CLICK TO DOWNLOAD SAMPLE REPORT

Cancer Deaths

The market is segmented by design into predesigned and customized, out of which, the predesigned segment is anticipated to hold the notable share in the global gene panel market over the forecast period on account of high demand for predesigned gene panels, backed by the affordable cost, easier availability, and broader application of these panels. On the basis of application, the cancer risk assessment segment is foreseen to gain the largest revenue share over the forecast period, owing to the rising prevalence of cancer across the world, especially in developed countries.

Major Macro-Economic Indicators Impacting the Market Growth


According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Gene Panel Market Regional Synopsis

On the basis of geographical analysis, the global gene panel market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Middle East and Africa region is estimated to witness modest growth over the forecast period on the back of rising cases of genetic diseases in the region, backed by lack of proper nutrition and care during pregnancy, and presence of carcinogens in the immediate surroundings. According to the data by the Eastern Mediterranean Health Journal of the World Health Organization (WHO), genetic disorders and congenital abnormalities appear in about 2%-5% of all live births in the region, causing around 50% of the total childhood deaths.

The market in the North America region is anticipated to gain the largest market share throughout the forecast period on the back of presence of major market players in the region, high healthcare expenditure, and government initiatives to curb the cancer death toll.

Gene Panel Market Share

The global gene panel market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global gene panel market includes the following segments:

By Technology

  • Amplicon-Based
  • Hybridization-Based
  • Others

By Design

  • Predesigned
  • Customized

By Application

  • Cancer Risk Assessment
  • Pharmacogenetics
  • Congenital Disorders
  • Others

By End-User

  • Research Institutes
  • Hospital
  • Diagnosis Centers
  • Pharmaceutical Companies
  • Others

Growth Drivers

  • Advancement in Genetic Biotechnology
  • Increasing Incidences of Cancer and Genetic Disorders
  • Ongoing Research and Development Activities


  • Lack of Workforce in Biotechnological Research
  • Lack of Health Awareness in Low and Middle-income Countries

Top Featured Companies Dominating the Market

  • Integrated DNA Technologies, Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Illumina, Inc.
  • BGI Group
  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • GENEWIZ Japan Corp.
  • Novogene Corporation
  • F. Hoffmann-La Roche AG
  • Personalis Inc.


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved